Literature DB >> 34993082

Ascending thoracic aortic aneurysm growth is minimal at sizes that do not meet criteria for surgical repair.

Arushi Gulati1, Joseph Leach2, Zhongjie Wang1, Yue Xuan2, Michael D Hope1, David A Saloner2, Liang Ge1, Elaine E Tseng1.   

Abstract

BACKGROUND: Historic studies of nonsyndromic ascending thoracic aortic aneurysms (aTAAs) reported that the typical aTAA growth rate was approximately 0.6 mm/year, but data were limited due to relatively few studies using computed tomography (CT) imaging. Our purpose was to reevaluate the annual growth rate of nonsyndromic aTAAs that do not meet criteria for surgical repair in veterans in the contemporary era, using modern CT imaging suitable for highly accurate and reproducible aneurysm measurement.
METHODS: Nonsurgical patients (diameter <5.5 cm) undergoing aneurysm surveillance at a Veterans Affairs Medical Center with repeat CT imaging performed 3 to 5 years apart were identified. Maximum diameter was determined by a single radiologist using multiplanar reformat-based measurements. Average rate of aneurysm growth was evaluated based on longest available follow-up.
RESULTS: Sixty-seven patients were included. Average follow-up time was 4.06±0.83 years. Patients were exclusively male, with average age of 68.1±6.0 years, and the majority had a history of smoking (n=52, 78%), hypertension (n=52, 78%), and dyslipidemia (n=48, 72%). Average baseline aneurysm diameter was 44.0±3.2 mm and average growth rate was 0.11±0.31 mm/year, with no difference in growth rate between patients with initial diameter ≤45 vs. >45 mm. Only 3 patients experienced clinically significant changes in diameter with magnitude greater than 5% of baseline.
CONCLUSIONS: In this veteran population, most patients did not experience significant annual aneurysm growth over up to 5 years of follow-up, regardless of initial diameter. Thus, in the modern era, aTAAs may not grow as quickly as previously described, which will be important in determining appropriate intervals for aneurysm surveillance based upon risk-benefit ratio. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Aortic aneurysms; diameter; growth; type A dissection

Year:  2022        PMID: 34993082      PMCID: PMC8666776          DOI: 10.21037/qims-21-55

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  29 in total

1.  Propranolol for small abdominal aortic aneurysms: results of a randomized trial.

Authors: 
Journal:  J Vasc Surg       Date:  2002-01       Impact factor: 4.268

Review 2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

3.  Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve.

Authors:  Ryan R Davies; Ryan K Kaple; Divakar Mandapati; Amy Gallo; Donald M Botta; John A Elefteriades; Michael A Coady
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

4.  Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size.

Authors:  Ryan R Davies; Lee J Goldstein; Michael A Coady; Shawn L Tittle; John A Rizzo; Gary S Kopf; John A Elefteriades
Journal:  Ann Thorac Surg       Date:  2002-01       Impact factor: 4.330

5.  Risk of Aortic Dissection in the Moderately Dilated Ascending Aorta.

Authors:  Joon Bum Kim; Matthew Spotnitz; Mark E Lindsay; Thomas E MacGillivray; Eric M Isselbacher; Thoralf M Sundt
Journal:  J Am Coll Cardiol       Date:  2016-09-13       Impact factor: 24.094

6.  Aortic diameter predicts acute type A aortic dissection in patients with Marfan syndrome but not in patients without Marfan syndrome.

Authors:  Eun Kyoung Kim; Seung Hyuk Choi; Kiick Sung; Wook Sung Kim; Yeon Hyeon Choe; Jae K Oh; Duk-Kyung Kim
Journal:  J Thorac Cardiovasc Surg       Date:  2013-07-21       Impact factor: 5.209

7.  The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Authors:  Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08       Impact factor: 5.209

8.  Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.

Authors:  G R Gadowski; D B Pilcher; M A Ricci
Journal:  J Vasc Surg       Date:  1994-04       Impact factor: 4.268

9.  Surveillance of moderate-size aneurysms of the thoracic aorta.

Authors:  Allison J McLarty; Muath Bishawi; Suresh Baba Yelika; A Laurie Shroyer; Jamie Romeiser
Journal:  J Cardiothorac Surg       Date:  2015-02-06       Impact factor: 1.637

10.  Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling Pathway.

Authors:  Tetsuya Sato; Mamoru Arakawa; Yasushi Tashima; Eitoshi Tsuboi; Grayson Burdon; Jeffrey Trojan; Tiffany Koyano; Young-Nam Youn; Kiril Penov; Albert J Pedroza; Mohammad Shabazzi; Itai Palmon; Marie Noel Nguyen; Andrew J Connolly; Atsushi Yamaguchi; Michael P Fischbein
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.